Marta Compte

2.3k total citations
42 papers, 1.7k citations indexed

About

Marta Compte is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Marta Compte has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Radiology, Nuclear Medicine and Imaging, 23 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Marta Compte's work include Monoclonal and Polyclonal Antibodies Research (27 papers), CAR-T cell therapy research (17 papers) and Virus-based gene therapy research (9 papers). Marta Compte is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (27 papers), CAR-T cell therapy research (17 papers) and Virus-based gene therapy research (9 papers). Marta Compte collaborates with scholars based in Spain, Denmark and United States. Marta Compte's co-authors include Luis Álvarez‐Vallina, Laura Sanz, Ana Álvarez‐Cienfuegos, Irene Guijarro-Muñoz, Ángel M. Cuesta, Rocío Navarro, Natalia Nuñez‐Prado, David Sánchez‐Martín, Vanesa Alonso-Camino and Seandean L. Harwood and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Marta Compte

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marta Compte Spain	22	858	563	485	415	267	42	1.7k
Brian R. Lawson United States	31	918 1.1×	756 1.3×	355 0.7×	1.7k 4.1×	124 0.5×	54	3.1k
Bo Guo China	31	1.4k 1.7×	699 1.2×	185 0.4×	657 1.6×	779 2.9×	86	2.7k
Jason Brayer United States	25	818 1.0×	1.2k 2.1×	171 0.4×	1.7k 4.2×	199 0.7×	67	3.2k
Jay Myers United States	19	519 0.6×	433 0.8×	74 0.2×	577 1.4×	124 0.5×	45	1.4k
Tomoaki Niimi Japan	22	703 0.8×	157 0.3×	125 0.3×	201 0.5×	134 0.5×	52	1.4k
Travis W. Bainbridge United States	15	773 0.9×	702 1.2×	108 0.2×	320 0.8×	194 0.7×	23	1.6k
Giuseppe Fiume Italy	22	927 1.1×	301 0.5×	94 0.2×	356 0.9×	252 0.9×	57	1.5k
Deepak Kanojia United States	22	773 0.9×	788 1.4×	65 0.1×	579 1.4×	292 1.1×	48	1.9k
Steven R. Barthel United States	20	741 0.9×	477 0.8×	100 0.2×	717 1.7×	98 0.4×	36	1.7k
Zdenka Jonak United States	20	548 0.6×	371 0.7×	212 0.4×	585 1.4×	62 0.2×	37	1.5k

Countries citing papers authored by Marta Compte

Since Specialization

Citations

This map shows the geographic impact of Marta Compte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Compte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Compte more than expected).

Fields of papers citing papers by Marta Compte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Compte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Compte. The network helps show where Marta Compte may publish in the future.

Co-authorship network of co-authors of Marta Compte

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Compte. A scholar is included among the top collaborators of Marta Compte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Compte. Marta Compte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rubio‐Pérez, Laura, Susana Frago, Marta Compte, et al.. (2024). Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity. Antibodies. 13(2). 34–34. 3 indexed citations

Tapia‐Galisteo, Antonio, Anaïs Jiménez-Reinoso, Marta Compte, et al.. (2024). Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. OncoImmunology. 13(1). 2338558–2338558. 8 indexed citations

Navarro, Rocío, Susana Frago, Miguel A. Morcillo, et al.. (2024). Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primates. Toxicology and Applied Pharmacology. 487. 116961–116961. 3 indexed citations

Tapia‐Galisteo, Antonio, Marta Compte, Luis Álvarez‐Vallina, & Laura Sanz. (2023). When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy. Theranostics. 13(3). 1028–1041. 65 indexed citations

Compte, Marta, Rocío Navarro, Antonio Tapia‐Galisteo, et al.. (2022). Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity. iScience. 25(9). 104958–104958. 12 indexed citations

Compte, Marta, Seandean L. Harwood, Jorge L. Martínez‐Torrecuadrada, et al.. (2021). Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR. Frontiers in Immunology. 11. 614363–614363. 6 indexed citations

Navarro, Rocío, Marta Compte, Luis Álvarez‐Vallina, & Laura Sanz. (2016). Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity. Frontiers in Immunology. 7. 480–480. 126 indexed citations

Soldevilla, Beatriz, Paloma Martín, Marta Compte, et al.. (2015). β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through Δ NP73 Negative Regulation in Colon Cancer. Clinical Cancer Research. 21(19). 4398–4409. 32 indexed citations

Álvarez‐Cienfuegos, Ana, Nekane Merino, Marta Compte, et al.. (2015). Bacterial secretion of soluble and functional trivalent scFv-based N-terminal trimerbodies. AMB Express. 5(1). 137–137.

10.

Compte, Marta, Ana Álvarez‐Cienfuegos, Natalia Nuñez‐Prado, et al.. (2014). Functional comparison of single-chain and two-chain anti-CD3-based bispecific antibodies in gene immunotherapy applications. OncoImmunology. 3(5). e28810–e28810. 24 indexed citations

11.

Guijarro-Muñoz, Irene, Marta Compte, Luis Álvarez‐Vallina, & Laura Sanz. (2013). Antibody Gene Therapy: Getting Closer to Clinical Application?. Current Gene Therapy. 13(4). 282–290. 18 indexed citations

12.

Alonso-Camino, Vanesa, David Sánchez‐Martín, Marta Compte, et al.. (2013). CARbodies: Human Antibodies Against Cell Surface Tumor Antigens Selected From Repertoires Displayed on T Cell Chimeric Antigen Receptors. Molecular Therapy — Nucleic Acids. 2. e93–e93. 29 indexed citations

13.

Sanz, Laura, et al.. (2011). Non-hematopoietic stem cells as factories for in vivo therapeutic protein production. Gene Therapy. 19(1). 1–7. 17 indexed citations

14.

Rodríguez, María E., Marta Compte, Elisa Cisneros, et al.. (2011). Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes and Cancer. 51(4). 409–418. 249 indexed citations

15.

Compte, Marta, Vanesa Alonso-Camino, Ángel M. Cuesta, et al.. (2010). Factory neovessels: engineered human blood vessels secreting therapeutic proteins as a new drug delivery system. Gene Therapy. 17(6). 745–751. 21 indexed citations

16.

Cuesta, Ángel M., David Sánchez‐Martín, Laura Sanz, et al.. (2009). In Vivo Tumor Targeting and Imaging with Engineered Trivalent Antibody Fragments Containing Collagen-Derived Sequences. PLoS ONE. 4(4). e5381–e5381. 48 indexed citations

17.

Alonso-Camino, Vanesa, David Sánchez‐Martín, Marta Compte, & Luis Álvarez‐Vallina. (2009). Lymphocyte Display: A Novel Antibody Selection Platform Based on T Cell Activation. PLoS ONE. 4(9). e7174–e7174. 16 indexed citations

18.

Compte, Marta, Belén Blanco, Fernando E. Serrano, et al.. (2007). Inhibition of tumor growth in vivo by in situ secretion of bispecific anti-CEA × anti-CD3 diabodies from lentivirally transduced human lymphocytes. Cancer Gene Therapy. 14(4). 380–388. 50 indexed citations

19.

Lobo, Víctor J. Sánchez‐Arévalo, Ángel M. Cuesta, Laura Sanz, et al.. (2006). Enhanced antiangiogenic therapy with antibody‐collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events. International Journal of Cancer. 119(2). 455–462. 27 indexed citations

20.

Cuesta, Ángel M., Eduardo Suárez, Martin Larsen, et al.. (2006). Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I. Immunology. 117(4). 502–506. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact